To drive scientific progress and increase digital medicine acceptance, the Digital Medicine Society (DiMe) has created The Playbook: Digital Clinical Measures, “ the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health.”
We are excited to be included in the Tour of Duty, a team of experienced tech, pharma, clinical leaders, regulators, and patient advocates driving the adoption of a shared foundation for the digital health field.
What ‘Tour of Duty’ participants are saying:
"We are on the brink of digital clinical measures going from being seen as "nice to have" to becoming critically important and absolutely necessary. The Playbook will help demonstrate to pharma companies, academic institutions and regulatory agencies the value of including digital endpoints in ALL clinical studies." David Caouette, Executive Director, Head of Digital Data Science & the PfIRe Lab, ECD, Pfizer
Read the full press release and more comments from other Tour of Duty participants about the impact of patient-centric digital technologies and how The Playbook can help guide best practices.
“This material is based on ‘The Playbook’ generated and maintained by the DiMe Society at playbook.dimesociety.org.”